EMvision Issues New Unquoted Options and Performance Rights Under Incentive Plan

EMvision Medical Devices Ltd. ( (AU:EMV) ) has issued an update.

EMvision Medical Devices has issued 400,000 unquoted options exercisable at $2.68 and expiring on 6 August 2029, along with 100,000 unquoted performance rights expiring on 6 February 2031, under its employee incentive scheme. The move modestly increases the company’s pool of unquoted equity-based incentives, reinforcing its focus on aligning staff and management interests with long-term shareholder value while not immediately affecting its quoted share capital on the ASX.

The most recent analyst rating on (AU:EMV) stock is a Buy with a A$3.15 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.

More about EMvision Medical Devices Ltd.

EMvision Medical Devices Ltd is an Australian-listed medical technology company that develops medical devices, with its securities traded on the ASX under the code EMV. The company utilises employee incentive schemes involving options and performance rights as part of its capital management and staff remuneration strategy.

Average Trading Volume: 34,628

Technical Sentiment Signal: Sell

Current Market Cap: A$168.2M

For a thorough assessment of EMV stock, go to TipRanks’ Stock Analysis page.